Oncology Business Management | Specialty

The OncLive Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

Welcome Back: A Dynamic and Innovative Field Deserves an Innovative Publication

August 16th 2010

The fields of oncology and biotechnology are entering a period of rapid growth and transformation. It is an exciting time for physicians, researchers, and allied healthcare professionals. We are honored to be apart of the process.

BIO-BUZZ: QUADRAMETï¿½: A New Option for Hormone-Refractory Prostate Cancer?

August 16th 2010

The treatment of hormone-refractory prostate cancer often represents a therapeutic challenge. As the most common malignancy in men and the second-leading cause of cancer death in the US, the number of patients requiring posthormonal therapy is increasing.

The Industry Insider: April 2007

August 13th 2010

Companies in the news: 1) AVAX and CTCA Collaborating for Cancer Therapies 2) Full Speed Ahead for GPC Biotech's Satraplatin 3) Bristol-Myers Squibb Company / Adnexus Therapeutics: Collaboration for New Oncology Compounds, and more

Flash Findings: A Global View of Biotechnology

August 13th 2010

The Organisation for Economic Co-operation and Development (OECD) (www.oecd.org) %u201Cis a group of 30 member countries sharing a commitment to democratic government and the market economy. Best known for its publications and its statistics, its work covers economic and social issues from macroeconomics, to trade, education, development and science and innovation.%u201D

The Academy: April 2007

August 13th 2010

The Academy delivers the latest news on biotechnology and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing farther into knowledge and discovery.

Politics & Policy: April 2007

August 13th 2010

This month's Fed Focus highlights such topics as Medicare reimbursement for cancer care and NCI budget cuts that affect cancer research.

The Rapid Reporter: April 2007

August 13th 2010

This month we report on presentations made at the BIO (Biotechnology Industry Organization)CEO & Investor Conference (February 11-14, 2007, New York, NY).

Physicians' Financial News for April 2007

August 13th 2010

Physicians' Financial News focuses on news-making and/or notable companies in the oncology/biotechnology sector. In this issue: 1) Avalon Could Earn More Than $200M in Deal with Merck & Co. 2) OXiGENE Sets Fiscal 2007 Priorities 3) Genentech Shares Fall Nearly 3% on Avastin Study, and more

The Virtual Window: Clinical Trial Reports--April 2007

August 13th 2010

The Clinical Trials reported in this issue include: PHASE I: 1) Cell Genesys and Medarex Remain Positive on Combination Immunotherapy Study 2) Active Biotech Achieves Success with TASQ for Prostate Cancer PHASE II: 1) Myriad Initiates Evaluation of Brain Cancer Drug that Crosses the Blood-Brain Barrier 2) Second Lung Cancer Trial Adds Data to Novel Therapy, and more

News Reports: April 2007

August 12th 2010

News reports featured in this issue: 1) Breast Cancer Spotlight 2) Expert Cancer Centers Cost-Effective for Managing Ovarian Cancer 3) New Breathalyzer

Oncology Workforce Study Predicts Oncologist Shortage By 2020

August 12th 2010

A study was commissioned by the Board of Directors of the American Society of Clinical Oncology (ASCO) to assess the supply and demand for oncology services through 2020.

GSK%u2019s Tykerbï¿½ Approved for Advanced Breast Cancer

August 12th 2010

With FDA approval for their advanced breast cancer drug Tykerbï¿½, GlaxoSmithKline is poised to reposition itself as a major player in the oncology business.

Moving Forward: Building a Community with Every Issue

August 12th 2010

We are privileged to bring you such stories as the shrinking oncology workforce and the exciting news about Tykerb (GSK's advanced breast cancer drug) as we continue evolving our publication both in style and content.

The Industry Insider: May 2007

August 12th 2010

News and information from the pharmaceutical industry. In this issue: 1) Multiple Deals for Affitech 2) Pfizer%u2019s Sutent Wins European Association of Urology Support 3) Aurora Breast MRI Will Meet Surge in Screening Demand, and more

Flash Findings: Cancer Facts: August 12, 2010

August 12th 2010

A collection of cancer statistics and facts

The Academy: May 2007

August 12th 2010

The Academy delivers the latest news on biotech and oncology research, providing a link between the clinical world of cancer care and the university researchers who are pushing the envelope of knowledge and discovery. In this issue: 1) Northwestern University: Anti-Cancer Flavonoids Synthesized 2) University of Wisconsin-Madison: Turning the Body's Immune System on Cancer, and more

Politics & Policy: May 2007

August 12th 2010

This month's Fed Focus highlights the CDC's HPV vaccine recommendations as well as changes in Medicare coverage of ESAs for cancer-related anemia. Our reports from

The Rapid Reporter: May 2007

August 12th 2010

This month we report on presentations made at the Association of Community Cancer Centers 33rd Annual National Meeting (March 28-31, 2007, Rockville, MD) and at a colorectal cancer meeting held at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University (March 28-31, 2007, Baltimore, MD).

Physicians' Financial News for May 2007

August 11th 2010

Physicians' Financial News focuses on news-making and/or notable companies in the oncology/biotech sector. In this issue: 1) Aveo Lands $477M Deal with Schering Plough 2) Eisai Grows Pharma-Based Cancer Pipeline in $325M Acquisition of Morphotek, and more

Clinical Trial Reports: May 2007

August 11th 2010

The Clinical Trials reported in this issue include: PHASE I: 1) Adherex Initiates Combination Trial of ADH-1 and Melphalan for Melanoma Treatment 2) Erimos Initiates Evaluation of First-In-Class Small Molecule Therapy for Glioma Brain Tumors PHASE II: 1) ChemGenex Treats First Patient in CML Trial, and more